Literature DB >> 26211746

Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells.

Meghan E McGee-Lawrence1,2, Lomeli R Carpio3, Ryan J Schulze4, Jessica L Pierce2, Mark A McNiven3,4, Joshua N Farr5, Sundeep Khosla5, Merry Jo Oursler3,5, Jennifer J Westendorf1,3.   

Abstract

Bone loss and increased marrow adiposity are hallmarks of aging skeletons. Conditional deletion of histone deacetylase 3 (Hdac3) in murine osteochondroprogenitor cells causes osteopenia and increases marrow adiposity, even in young animals, but the origins of the increased adiposity are unclear. To explore this, bone marrow stromal cells (BMSCs) from Hdac3-depleted and control mice were cultured in osteogenic medium. Hdac3-deficient cultures accumulated lipid droplets in greater abundance than control cultures and expressed high levels of genes related to lipid storage (Fsp27/Cidec, Plin1) and glucocorticoid metabolism (Hsd11b1) despite normal levels of Pparγ2. Approximately 5% of the lipid containing cells in the wild-type cultures expressed the master osteoblast transcription factor Runx2, but this population was threefold greater in the Hdac3-depleted cultures. Adenoviral expression of Hdac3 restored normal gene expression, indicating that Hdac3 controls glucocorticoid activation and lipid storage within osteoblast lineage cells. HDAC3 expression was reduced in bone cells from postmenopausal as compared to young women, and in osteoblasts from aged as compared to younger mice. Moreover, phosphorylation of S424 in Hdac3, a posttranslational mark necessary for deacetylase activity, was suppressed in osseous cells from old mice. Thus, concurrent declines in transcription and phosphorylation combine to suppress Hdac3 activity in aging bone, and reduced Hdac3 activity in osteochondroprogenitor cells contributes to increased marrow adiposity associated with aging.
© 2015 American Society for Bone and Mineral Research. © 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  AGING; HSD11B1; LIPID DROPLETS; OSTEOPOROSIS; RUNX2

Mesh:

Substances:

Year:  2015        PMID: 26211746      PMCID: PMC4758691          DOI: 10.1002/jbmr.2602

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  88 in total

1.  Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study.

Authors:  K Casazza; L J Hanks; B Hidalgo; H H Hu; O Affuso
Journal:  Bone       Date:  2011-09-13       Impact factor: 4.398

2.  Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes.

Authors:  Lige Song; Minlin Liu; Noriaki Ono; F Richard Bringhurst; Henry M Kronenberg; Jun Guo
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

Review 3.  Marrow fat metabolism is linked to the systemic energy metabolism.

Authors:  Beata Lecka-Czernik
Journal:  Bone       Date:  2011-07-04       Impact factor: 4.398

4.  Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle.

Authors:  Zheng Sun; Nikhil Singh; Shannon E Mullican; Logan J Everett; Li Li; Lijun Yuan; Xi Liu; Jonathan A Epstein; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

5.  Redundant control of adipogenesis by histone deacetylases 1 and 2.

Authors:  Michael Haberland; Michele Carrer; Mayssa H Mokalled; Rusty L Montgomery; Eric N Olson
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

6.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

7.  Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.

Authors:  Robert S Weinstein; Chao Wan; Qinglan Liu; Ying Wang; Maria Almeida; Charles A O'Brien; Jeff Thostenson; Paula K Roberson; Adele L Boskey; Thomas L Clemens; Stavros C Manolagas
Journal:  Aging Cell       Date:  2009-12-28       Impact factor: 9.304

8.  Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development.

Authors:  Toshihide Mizoguchi; Sandra Pinho; Jalal Ahmed; Yuya Kunisaki; Maher Hanoun; Avital Mendelson; Noriaki Ono; Henry M Kronenberg; Paul S Frenette
Journal:  Dev Cell       Date:  2014-05-12       Impact factor: 12.270

9.  Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro.

Authors:  Alexandre Elbaz; Xiying Wu; Daniel Rivas; Jeffrey M Gimble; Gustavo Duque
Journal:  J Cell Mol Med       Date:  2009-03-27       Impact factor: 5.310

10.  Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.

Authors:  Zheng Sun; Russell A Miller; Rajesh T Patel; Jie Chen; Ravindra Dhir; Hong Wang; Dongyan Zhang; Mark J Graham; Terry G Unterman; Gerald I Shulman; Carole Sztalryd; Michael J Bennett; Rexford S Ahima; Morris J Birnbaum; Mitchell A Lazar
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

View more
  35 in total

Review 1.  Mechanisms of marrow adiposity and its implications for skeletal health.

Authors:  Annegreet G Veldhuis-Vlug; Clifford J Rosen
Journal:  Metabolism       Date:  2016-11-27       Impact factor: 8.694

2.  Intracellular lipid droplets support osteoblast function.

Authors:  Elizabeth Rendina-Ruedy; Anyonya R Guntur; Clifford J Rosen
Journal:  Adipocyte       Date:  2017-07-20       Impact factor: 4.534

3.  Mechanical loading disrupts osteocyte plasma membranes which initiates mechanosensation events in bone.

Authors:  Kanglun Yu; David P Sellman; Anoosh Bahraini; Mackenzie L Hagan; Ahmed Elsherbini; Kayce T Vanpelt; Peyton L Marshall; Mark W Hamrick; Anna McNeil; Paul L McNeil; Meghan E McGee-Lawrence
Journal:  J Orthop Res       Date:  2017-08-11       Impact factor: 3.494

4.  Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.

Authors:  Marina Feigenson; Lomeli Carpio Shull; Earnest L Taylor; Emily T Camilleri; Scott M Riester; Andre J van Wijnen; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2017-09-18       Impact factor: 6.741

Review 5.  Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues.

Authors:  Anuj K Sharma; Xingming Shi; Carlos M Isales; Meghan E McGee-Lawrence
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 6.  Epigenetic regulation of bone cells.

Authors:  Kyung Hyun Park-Min
Journal:  Connect Tissue Res       Date:  2016-04-14       Impact factor: 3.417

7.  Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.

Authors:  F-S Wang; W-S Lian; W-T Weng; Y-C Sun; H-J Ke; Y-S Chen; J-Y Ko
Journal:  Osteoporos Int       Date:  2016-04-14       Impact factor: 4.507

8.  The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

Authors:  Jessica L Pierce; Ke-Hong Ding; Jianrui Xu; Anuj K Sharma; Kanglun Yu; Natalia Del Mazo Arbona; Zuleika Rodriguez-Santos; Paul Bernard; Wendy B Bollag; Maribeth H Johnson; Mark W Hamrick; Dana L Begun; Xing M Shi; Carlos M Isales; Meghan E McGee-Lawrence
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

Review 9.  The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Authors:  Joshua N Farr; Maria Almeida
Journal:  J Bone Miner Res       Date:  2018-08-13       Impact factor: 6.741

10.  Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Meghan E McGee-Lawrence; Megan M Weivoda; Daniel D Poston; Amel Dudakovic; Ming Xu; Tamar Tchkonia; James L Kirkland; Andre J van Wijnen; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Sci Signal       Date:  2016-08-09       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.